Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
Holding KALA?
Track your performance easily

Kala Pharmaceuticals (KALA) Income Statement

1,448 Followers

Kala Pharmaceuticals Income Statement

Last quarter (Q2 2024), Kala Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Kala Pharmaceuticals's net income was $-9.58M. See Kala Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
--$ 3.89M$ 11.24M$ 6.36M$ 6.07M
Cost of Revenue
--$ 2.56M$ 4.10M$ 3.17M-
Gross Profit
--$ 1.33M$ 7.14M$ 3.19M$ 6.07M
Operating Expense
$ 34.58M$ 34.33M$ 82.69M$ 141.49M$ 102.59M$ 90.28M
Operating Income
$ -39.92M$ -39.66M$ -81.71M$ -130.25M$ -96.23M$ -84.21M
Net Non Operating Interest Income Expense
$ -2.06M$ -3.10M$ -6.60M$ -8.28M$ -8.10M$ -6.12M
Other Income Expense
$ -6.86M$ -4.77M$ 43.14M$ 4.08M--
Pretax Income
$ -41.16M$ -42.20M$ -44.82M$ -146.02M$ -97.98M$ -90.33M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -38.72M$ -42.20M$ -44.82M$ -142.60M$ -104.33M$ -90.33M
Basic EPS
$ -13.36$ -17.35$ -29.48$ -109.50$ -99.50$ -138.00
Diluted EPS
$ -13.36$ -17.35$ -29.48$ -109.50$ -99.50$ -138.00
Basic Average Shares
$ 11.11M$ 2.43M$ 1.52M$ 1.30M$ 1.05M$ 684.20K
Diluted Average Shares
$ 11.11M$ 2.43M$ 1.52M$ 1.30M-$ 684.20K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 39.92M$ 34.33M$ 85.25M$ 141.49M$ 102.59M$ 90.28M
Net Income From Continuing And Discontinued Operation
$ -38.72M$ -42.20M$ -44.82M$ -142.60M$ -104.33M$ -90.33M
Normalized Income
$ -37.64M$ -32.53M-$ -116.67M--
Interest Expense
------
EBIT
$ -35.25M$ -36.38M$ -37.56M$ -134.22M$ -95.74M$ -81.85M
EBITDA
$ -34.35M$ -36.08M$ -37.02M$ -133.25M$ -94.83M$ -80.05M
Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis